Archive for the ‘behind a paywall’ Category
It would seem that resorting to legal means to avoid editorial notices doesn’t always work.
We’re coming to that conclusion after seeing yet another notice for Mario Saad, based at the University of Campinas in São Paulo, Brazil. In this case, it’s an expression of concern from the Journal of Endocrinology, on a 2005 paper that lists Saad as the second-to-last author. According to the notice, the journal is concerned the paper contains spliced and duplicated images; although the authors offered to repeat the experiments, the journal considered that potential delay “unacceptable.”
Despite Saad’s legal efforts, he is now up to 11 retractions, along with multiple expressions of concern.
Here’s the full text of the notice (which is paywalled, tsk tsk):
A pathology journal is retracting two papers after an investigation at the last author’s institution in Germany found evidence of scientific misconduct.
The notice for both papers cites an investigation involving Regine Schneider-Stock, who studies cancer biology at the Friedrich Alexander-University Erlangen-Nuremberg (FAU). Meanwhile, another 2005 paper that lists Schneider-Stock as the first author was retracted in October, noting evidence of image manipulation.
The most recent retractions, from the American Journal of Pathology, note that FAU declined to provide the journal with details of its investigation beyond a prepared statement:
A lab at the University of California, Los Angeles has retracted two papers for duplicated images.
These retractions — in the Journal of Immunology — represent the second and third retractions for the lab head; he lost another paper after one of his former students confessed to manipulating images.
Unfortunately, Suzuki’s admission in 2014 wasn’t the end of the troubles for lab head Benjamin Bonavida, who recently issued two additional retractions in the Journal of Immunology, only one of which includes Suzuki as a co-author.
Bonavida told us the university received allegations (he’s not sure from who) that some of the control gels were duplicated; he didn’t agree, but couldn’t produce the original gels to disprove it. We asked if any more retractions were coming from Bonavida, who has since retired from running a lab:
Several duplications in the work of a prominent diabetes researcher were the result of negligence, but there is not enough evidence to support charges of misconduct, according to an investigation at her university in Germany.
Recently, we’ve reported on several notices for papers co-authored by Kathrin Maedler, a researcher at the University of Bremen. So far, Maedler has one retraction, multiple corrections, and two expressions of concern to her name, after several of her papers were questioned on PubPeer. Previously, the University of Zurich in Switzerland — where Maedler completed her PhD in 2002 — determined there was a lack of evidence to support allegations of misconduct in papers that were part of her doctoral thesis.
According to an editor’s note, published in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, the journal received confirmation from all three authors that the aforementioned researcher should be removed from the author list during proofing stage. However, the researcher whose name was omitted — Nahid Nishat of the Jamia Millia Islamia in Jamia Nagar, New Delhi, India — later contacted the journal claiming that she didn’t okay this move.
Nishat told Retraction Watch that she believes the two listed authors on the paper wrote to the journal on her behalf to remove her name: Read the rest of this entry »
Bharat Aggarwal, a highly cited cancer researcher who retired last year from MD Anderson, has logged two retractions following an investigation into his work, bringing his total to nine.
Aggarwal has threatened to sue us in the past, and told us that MD Anderson has been investigating his work. Earlier this year, Biochemical Pharmacology retracted seven studies of which he is the only common author, noting the “data integrity has become questionable.” Now, he’s earned two more retractions in Molecular Pharmacology, both for “inappropriate” or “unacceptable” image manipulation.
Both of the notices are paywalled (tsk, tsk). Here’s one for “Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells:” Read the rest of this entry »
Martin W. F. Stone was a philosophy professor at the University of Leuven — by one account “widely admired and highly respected” — until 2010, when an investigation at the school concluded that his work is “highly questionable in terms of scientific integrity.” Over the past several years, he has racked up retractions, earning his 14th this spring, and spot #30 on our leaderboard.
Stone’s retractions were brought to our attention by philosopher Michael Dougherty, who found a notice for “Michael Baius (1513–89) and the Debate on ‘Pure Nature’: Grace and Moral Agency in Sixteenth-Century Scholasticism,” a chapter in Springer’s Moral Philosophy on the Threshold of Modernity.
The standard in transparency? Editor praises author honesty that led to retraction in anesthesia journal
Sometimes, a junior member of the team sees things an editor-in-chief misses.
Regular readers know that we’re always delighted when we get a chance to commend researchers and journals for doing the right thing. Here’s an example that sets the standard.
Anesthesia & Analgesia (A&A) is retracting a 2015 paper which purportedly found important differences in patient outcomes based on the quality of their anesthesiologists. The trouble with the article: Read the rest of this entry »
Two retractions and three corrections have appeared for a group of Duke researchers that already have 10+ retractions under their belts.
The reasoning behind them echoes that which we’ve seen before in notices for Michael Foster and Erin Potts-Kant: Following an inquiry from the university, the journals were informed that some of the data or results weren’t reliable, and not all of the experiments could be repeated.
A colleague aware of the case said that researchers are still working to repeat experiments from papers by Potts-Kant and Foster. It is not known how many more papers might be corrected or retracted. Duke University is fully supporting the validation of these experiments, the source told us.
Foster has retired from Duke, a spokesperson for the university confirmed. Read the rest of this entry »
Recently, Robert Geller of the University of Tokyo brought an interesting issue to our attention. In following a particular paper that had been flagged with concerns on PubPeer, he saw that the journal had eventually retracted it. Even though the journal was sold under a subscription-based model, it made the retraction notice available outside the paywall– per the recommendations of the Committee on Publication Ethics (COPE).
The paper itself now included a link to the retraction notice – also recommended by COPE – but the retracted article remained behind the paywall. In other words, to read the retracted paper, non-subscribers would have to pay 3300 Yen (about $30).
Geller contacted us, concerned that the journal was continuing to profit from a retracted paper.
It’s a question we’ve never considered before: Read the rest of this entry »